Your browser doesn't support javascript.
loading
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
Tomizawa, D; Koh, K; Sato, T; Kinukawa, N; Morimoto, A; Isoyama, K; Kosaka, Y; Oda, T; Oda, M; Hayashi, Y; Eguchi, M; Horibe, K; Nakahata, T; Mizutani, S; Ishii, E.
Affiliation
  • Tomizawa D; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan. dtomizawa.ped@tmd.ac.jp
Leukemia ; 21(11): 2258-63, 2007 Nov.
Article in En | MEDLINE | ID: mdl-17690691
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Gene Rearrangement / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Infant / Male / Newborn Country/Region as subject: Asia Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2007 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Gene Rearrangement / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Female / Humans / Infant / Male / Newborn Country/Region as subject: Asia Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2007 Document type: Article Affiliation country: Country of publication: